CINELLU, Maria Agostina
 Distribuzione geografica
Continente #
NA - Nord America 19.406
AS - Asia 5.301
EU - Europa 3.395
SA - Sud America 3.169
AF - Africa 222
Continente sconosciuto - Info sul continente non disponibili 76
OC - Oceania 13
AN - Antartide 1
Totale 31.583
Nazione #
US - Stati Uniti d'America 19.184
BR - Brasile 2.827
SG - Singapore 2.087
CN - Cina 1.743
UA - Ucraina 1.230
DE - Germania 454
SE - Svezia 453
VN - Vietnam 389
IT - Italia 371
HK - Hong Kong 362
FR - Francia 206
FI - Finlandia 200
GB - Regno Unito 192
AR - Argentina 131
BD - Bangladesh 84
IN - India 84
RU - Federazione Russa 81
TR - Turchia 81
MX - Messico 79
CA - Canada 78
IQ - Iraq 66
ZA - Sudafrica 65
JP - Giappone 50
UZ - Uzbekistan 50
EC - Ecuador 48
ID - Indonesia 48
CO - Colombia 47
MA - Marocco 43
PK - Pakistan 38
VE - Venezuela 38
BE - Belgio 32
JO - Giordania 28
NL - Olanda 26
KE - Kenya 25
TN - Tunisia 25
PY - Paraguay 24
ES - Italia 23
KR - Corea 23
PL - Polonia 23
KZ - Kazakistan 19
DZ - Algeria 17
AZ - Azerbaigian 16
NP - Nepal 16
UY - Uruguay 16
CL - Cile 15
LB - Libano 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
IE - Irlanda 13
IR - Iran 13
AU - Australia 12
PE - Perù 12
SA - Arabia Saudita 12
CZ - Repubblica Ceca 10
GT - Guatemala 9
PA - Panama 9
BA - Bosnia-Erzegovina 8
BY - Bielorussia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
HN - Honduras 8
JM - Giamaica 8
LT - Lituania 8
OM - Oman 8
RO - Romania 8
BO - Bolivia 7
CI - Costa d'Avorio 7
SN - Senegal 7
AT - Austria 6
ET - Etiopia 6
EU - Europa 6
GR - Grecia 6
IL - Israele 6
KG - Kirghizistan 6
NI - Nicaragua 6
PH - Filippine 6
PT - Portogallo 6
AL - Albania 5
BG - Bulgaria 5
GE - Georgia 5
PS - Palestinian Territory 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
CH - Svizzera 4
HU - Ungheria 4
MY - Malesia 4
BH - Bahrain 3
ML - Mali 3
MN - Mongolia 3
NG - Nigeria 3
QA - Qatar 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BN - Brunei Darussalam 2
GY - Guiana 2
LV - Lettonia 2
MD - Moldavia 2
PR - Porto Rico 2
Totale 31.490
Città #
Dallas 12.313
Singapore 1.131
Chandler 1.123
Jacksonville 728
San Jose 670
Ashburn 416
Princeton 369
Hong Kong 346
Beijing 343
Nanjing 272
Council Bluffs 255
Columbus 235
Dearborn 227
Santa Clara 217
São Paulo 178
Wilmington 174
Lauterbourg 157
Ann Arbor 139
Ho Chi Minh City 135
Los Angeles 113
Boardman 108
Shanghai 108
Nanchang 102
Sassari 96
Woodbridge 91
Belo Horizonte 79
Hanoi 79
Rio de Janeiro 77
Washington 73
Shenyang 67
Tianjin 67
Hebei 64
Brasília 55
Changsha 52
The Dalles 49
Mountain View 48
Kunming 46
New York 46
Jiaxing 45
Tokyo 44
Tashkent 43
Andover 41
Curitiba 41
Houston 40
San Francisco 40
Hangzhou 38
Porto Alegre 37
Johannesburg 33
Buffalo 32
Jinan 32
Toronto 32
Brussels 31
Baghdad 29
Zhengzhou 28
Amman 26
Milan 26
Ningbo 26
Salvador 26
San Mateo 26
Guarulhos 25
Campinas 24
Goiânia 24
Orem 24
Da Nang 23
Ribeirão Preto 23
Brooklyn 22
Florence 22
Buenos Aires 21
Leawood 21
Nairobi 20
Seoul 20
Ankara 19
Chicago 19
Dhaka 19
Frankfurt am Main 19
Guangzhou 19
Jakarta 19
Munich 19
Phoenix 19
Rome 19
Warsaw 19
Atlanta 18
Augusta 18
Denver 18
London 18
Norwalk 18
Santo André 18
Contagem 17
Maceió 17
Manchester 17
Osasco 17
Haiphong 16
Izmir 16
Mexico City 16
Montreal 16
São Bernardo do Campo 16
Baku 15
Caxias do Sul 15
Monmouth Junction 15
Piracicaba 15
Totale 22.339
Nome #
1,1' BIS(DIPHENYLPHOSPHINO)FERROCENE COMPLEXES OF PLATINUM(II) AND PLATINUM(I) - CRYSTAL AND MOLECULAR-STRUCTURE OF [(FE(ETA-5-C5H4PPH2)PT(MU-H)(MU-CO)PT(FE(ETA-5-C5H4PPH2)2)][BF4]-0.5H2O 10.315
[Au2(phen2Me)2(?-O)2](PF6)2, a novel dinuclear gold(III) complex showing excellent antiproliferative properties 193
Assembly of symmetrical and unsymmetrical platinum(II) rollover complexes with bidentate phosphine ligands 192
ADDUCTS AND CYCLOMETALLATED DERIVATIVES OF PALLADIUM(II) WITH SOME 1,4-BENZODIAZEPIN-2-ONES - CRYSTAL AND MOLECULAR-STRUCTURE OF TRANS-DICHLOROBIS[7-CHLORO-1-(CYCLOPROPYLMETHYL)-1,3-DIHYDRO-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE]PALLADIUM(II) 182
Catalytic and Biological studies of Au(III) complexes with pyridinyl-oxazoline ligands 181
Chemistry, antiproliferative properties, tumor selectivity and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study 180
Auraoxetanes as Plausible Intermediates in the Oxidation of Alkenes by Oxygen- Transfer Reaction from Gold(III) Oxo Complexes. 178
Gold(III) Adducts with Chiral Pyridinyl-Oxazolines. Synthesis, Reactivity of the Coordinated Ligands and Structural Characterizations 175
Chiral cyclometalation of 6-(1-phenylbenzyl)-2,2’-bipyridine. 173
ADDUCTS AND CYCLOMETALATED DERIVATIVES OF PALLADIUM(II) WITH 2-(1-METHYLBENZYL)PYRIDINE RID D-3096-2011 169
Activation of a C-H bond in a pyridine ring. Reaction of 6-substituted 2,2 '-bipyridines with methyl and phenyl platinum(II) derivatives: N ',C(3)-"rollover" cyclometalation 167
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds. 167
[Au(pyb-H)(mnt)]: A novel gold(III) 1,2-dithiolene cyclometalated complex with antimicrobial activity (pyb-H = C-deprotonated 2-benzylpyridine; mnt = 1,2-dicyanoethene-1,2-dithiolate) 165
Chemistry of Gold(III) Complexes with Nitrogen and Oxygen Ligands 163
New complexes of palladium(II) with chelating heterocyclic nitrogen ligands. Characterization and catalytic activity in CO-styrene copolimerization. Crystal structure of [Pd(bipy)2][BAr’4]2, Ar’ = [3,5-(CF3)2C6H3] 162
Complessi di Oro(III) con leganti pincer NCN piridinici 162
C(3) aurated 1,4-benzodiazepin-2-ones. Synthesis and characterization. Crystal structure of (L)Au[P(C6H4CH3-4)(3)] (HL = 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, DIAZEPAM) 162
Chiral methyl derivatives of platinum(II) with 2-substituted pyridines 162
Complessi mono e dinucleari di oro (i) e oro (iii): applicazioni in campo farmacologico e catalitico 161
New Variations on the Theme of Gold(III) C ∧ N ∧ N Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization 159
Cytotoxic Properties of a New Organometallic Platinum(II) Complex and its Gold(I) Heterobimetallic Derivatives 158
Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage 158
Gold(III) Complexes with 2-Substituted Pyridines as Experimental Anticancer Agents: Solution Behaviour, Reaction with Model Proteins, Antiproliferative Properties. 157
Reactivity of Ph2P(O)py-2 with platinum(II) alkyl derivatives - Building-up of a chiral phosphorus atom through C,N-cyclometallation RID D-3096-2011 152
Gold(III) adducts of 2-vinyl- and 2-ethylpyridine and cyclometallated derivatives of 2-vinylpyridine: Crystal structure of the cyclometallated derivative [Au(k(2)-C,N-CH(2)CH(Cl)-C(5)H(4)N)(PPh(3))Cl][PF(6)] RID D-3096-2011 151
Synthesis, Solution Behavior, Molecular and Supramolecular Structures of the Water- soluble Gold(I) Saccharinate Complexes M[Au(Sac)2] (M = Na, K, NH4) 150
Rollover-assisted C(sp2)-C(sp3) bond formation 149
Dinuclear platinum(II) complexes with bridging twofold deprotonated 2,2 ': 6 ',2 ''-terpyridine. New molecules with a 3,5-diplatinated-pyridyl inner core: [Pt-2(terpy-2H)(Me)(2)(L)(2)], [Pt-2(terpy-2H)(X)(2)(L)(2)] and [Pt-2(terpy-2H)(H)(2)(L)(2)] (L = neutral ligand; X = halide) - Crystal and molecular structure of [Pt-2(terpy-2H)(Cl)(2)(PPh3)(2)] RID D-3096-2011 149
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 147
Synthesis and properties of gold alkene complexes. Crystal structure of [Au(bipyoXyl)(g2-CH2=CHPh)](PF6) and DFT calculations on the model cation [Au(bipy)(g2-CH2=CH2)]+ 147
Complessi mono- ed eterodinucleari di oro, platino e palladio: sintesi e caratterizzazione 145
N,C "Rollover" cyclometalated platinum(II) hydrides: Mono- and polynuclear derivatives 144
Gold(III) derivatives with a-diimines as potential antitumor agents: synthesis and characterization 144
A Gold(III) Push-Pull Mixed-Ligand Complex for ICT Applications: Synthesis, Characterization, and DFT Investigation 144
N^N^C Platinum(II) and Palladium(II) cyclometallates of 6,6’-diphenyl-2,2’-bipyridine, L. Crystal and molecular structure of [Pd(L-H)Cl] 143
m-Oxo and alkoxo complexes of gold(III) with 6-alkyl-2,2’-bipiridines. Synthesis, characterization and X-ray structures 143
Biological studies on a new class of gold complexes with pyridinyl-benzoimidazole 143
Dinuclear Gold(III) Complexes as Potential Anticancer Agents. Structure, Reactivity and Biological Profile of a Series of Gold(III) Oxo-Bridged Derivatives 142
Cyclopalladation of 6-substituted-2,2’-bipyridines. Metallation of unactivated methyl groups vs. aromatic C-H activation 141
Large Effect of a Small Substitution: Competition of Dehydration with Charge Retention and Coulomb Explosion in Gaseous [(bipyR)Au(μ-O)2Au(bipyR)]2+ Dications 139
Complessi pincer NCN di Au(III) quali possibili agenti antitumorali 137
Synthesis, structural characterization and in vitro cytotoxicity of gold complexes with 2-(2-pyridyl)benzimidazole. Gold)III) vs. cold(I), mono- vs. binuclear derivatives 136
Cyclometalated Platinum(II) hydrides with nitrogen ligands 135
FAB Mass Spectrometry of Palladium(II) Derivatives with 1,4-Benzodiazepin-2-ones: Evidence of the Stability of Cyclometallated Species 135
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study 135
Gold-Alkyne Complexes 134
Metallation of unactivated methyl groups. Platinum(II) derivatives with 6-alkyl-2,2’-bipyridines 134
Biological studies on a new class of gold complexes with pyridinyl-benzoimidazole 133
Electrochemical properties of gold(III) complexes with 2,2 '-bipyridine and oxygen ligands 132
Palladium(II) and platinum(II)-C-(3)-substituted 2,2 '-bipyridines RID D-3096-2011 132
Cyclometalation of 2,2'-Bipyridine, Mono- and Dinuclear C,N Platinum(II) Derivatives 131
Electrochemical behaviour of cyclometallated gold(III) complexes. Evidence of transcyclometallation in the fate of electroreduced species 130
Complessi NCN di Oro(III) con leganti pincer aromatici con gruppi piridilici 129
Electronic and steric effects in rollover C-H bond activation 128
Synthesis and Characterization of Square-planar Palladium(II), Platinum(II) and Rhodium(I) Complexes with a Chiral Pyridylphosphine Hybrid Ligand 127
Gold(III) Complexes with 2-Substituted Pyridines as Experimental Anticancer Agents: Solution Behaviour, Reactions with Model Proteins, Antiproliferative Properties 127
Platinum(II), palladium(II) and gold(III) adducts and cyclometalated derivatives of 6-methoxy-2,2’-bipyridine: A comparative study 126
mu-Oxo and alkoxo complexes of gold(III) with 6-alkyl-2,2 '-bipyridines. Synthesis, characterization and X-ray structures 126
Synthesis, characterization and evaluation of gold complexes as anti microbial compounds 125
Platinum(II)-Cyclometalated “Roll-over” Complexes with a Chiral Pinene-Derived 2,2'-Bipyridine 125
Unusual Platinum Hydrides With Nitrogen Ligands 124
Cytotoxic gold compounds showing selectivity between cancerous and normal cells: synthesis and biological characterization. 123
Rollover cyclometalation with 2-(2’-Pyridyl)quinoline 123
Heterobimetallic rollover derivatives 123
Synthesis and molecular structure of [Pd{CH2CH2C(O)Me}(HL)][BAr '(4)] (HL=6-Me-2,2 '-bipyridine, Ar '=3,5-(CF3)(2)C6H3), an intermediate relevant to ethene/CO copolymerization 123
Exploring the potential of gold(III) cyclometallated compounds as cytotoxic agents: variations on the C^N theme 122
Complessi di oro con leganti imidazolici di interesse farmacologico 121
Reactivity of 1,3-bis(2-pyridyl)benzene, N boolean AND CH boolean AND N, with gold(III) chlorides: salts, adducts and cyclometalated pincer derivatives. Crystal and molecular structures of [HN boolean AND CH boolean AND N][AuCl4], [Au(N boolean AND C boolean AND N)Cl][PF6] and [Au(N boolean AND C boolean AND N)Cl(PPh3)(2)][PF6] 121
Synthesis and Characterization of Gold(III) Adducts and Cyclometallated Derivatives with 6-Benzyl- and 6-Alkyl-2,2’-bipyridines 120
The first gold(III) dinuclear cyclometallated derivatives with a single oxo bridge 120
Cyclometallated Derivatives of Platinum(II) derived from 6-(tert-Butyl)-2,2’-bipyridine (HL). Crystal and Molecular Structure of [Pt(L)Cl] 119
Palladium(II) and platinum(II) derivatives with N,O ligands 118
Protein Recognition of Gold-Based Drugs: 3D Structure of the Complex Formed When Lysozyme Reacts with Aubipyc 118
Gold saccharinato derivatives as potential antimalarial agents 118
Reaction of gold(III) oxo complexes with alkenes. Synthesis of unprecedented gold alkene complexes, [Au(N,N)(alkene)][PF6]. Crystal structure of [Au(bipy(ip))(eta(2)-CH2=CHPh)][PF6] (bipy(ip)=6-isopropyl-2,2 '-bipyridine) 117
SYNTHESIS AND CHARACTERIZATION OF GOLD(III) ADDUCTS AND CYCLOMETALATED DERIVATIVES WITH 2-SUBSTITUTED PYRIDINES - CRYSTAL-STRUCTURE OF [AU(NC5H4(CME(2)C(6)H(4))-2)CL-2] 116
CYCLOMETALATED DERIVATIVES OF PLATINUM(II) DERIVED FROM 1,4-BENZODIAZEPIN-2-ONES - CRYSTAL AND MOLECULAR-STRUCTURE OF PT(L)(HL)CL (HL=7-CHLORO-1,3-DIHYDRO-1-METHYL-5-PHENYL-2H-1,4-BENZODIAZEPIN-2-ONE, DIAZEPAM), A MOLECULE CONTAINING A NEUTRAL AND A DEPROTONATED 1,4-BENZODIAZEPIN-2-ONE 116
Gold(III) derivatives with α-diimines as potential antitumor agents: synthesis and characterisation 116
Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles. 115
Comportamento catodico di addotti di Au(III) con 2,2’-bipiridine 114
Complessi di Pt(II) con 1,2-bis(2-piridil)benzene 114
Fast-atom Bombardment Mass Spectrometry and Collisional Spectroscopy in the Structural Characterization of Underivatized 1,4-Benzodiazepines 114
FAB Mass Spectrometry of Au(I) Complexes with 1,4-Benzodiazepin-2-ones 113
Synthesis and Characterization of Palladium(II) and Platinum(II) Adducts and Cyclometalated Complexes of 6,6 '-Dimethoxy-2,2 '-bipyridine: C(sp(3))-H and C(sp(2))-H Bond Activations 113
Synthesis of the first C-2 cyclopalladated derivatives of 1,3-bis(2-pyridyl)benzene. Crystal structures of [Hg(N-C-N)Cl], [Pd(N-C-N)Cl], and [Pd-2(N-C-N)(2)(mu-OAc)](2)[Hg2Cl6]. Catalytic activity in the heck reaction 112
Inhibition of Na+/K+-ATPase and cytotoxicity of a few selected gold(III) complexes. 112
Synthesis and characterization of mononuclear amidogold(III) complexes - Crystal structure of [Au(N2C10H7(CMe2C6H4)-6](NHC6H3Me2-2,6)][PF6] - Oxidation of 4-methylaniline to azotoluene RID D-3096-2011 112
Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells 112
Synthesis, structural characterization and in vitro cytotoxicity of gold complexes with 2-(2-pyridyl)benzimidazole. Gold(III) vs. Gold(I), mononuclear vs. binuclear derivatives 111
Cyclometallated Derivatives of Palladium(II) with 1,4-Benzodiazepin-2-ones. Crystal Structure of (L-H)Pd(PPh3)Cl.CHCl3 (L = Prazepam: 7-chloro-1-cyclopropylmethyl-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one). Synthesis of Isoindolo-[2,1-d][1,4] benzodiazepine Derivatives by Reaction of [(L-H)PdCl]2 Species with Carbon Monoxide 111
Modification of HIV-1 reverse transcriptase and integrase activity by gold(III) complexes in direct biochemical assays. 111
Gold(III) derivatives with anionic oxygen ligands: mononuclear hydroxo, alkoxo and acetato complexes. Crystal structure of [Au(bpy)(OMe)(2)][PF6] 111
Solution chemistry and cytotoxic properties of novel organogold(III) compounds 110
Mono and Dinuclear Gold(I) Complexes with Neutral and Deprotonated 1,4-Benzodiazepin-2-ones. Crystal and Molecular Structure of (L-H)Au(PPh3).Et2O, where L = 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one, NITRAZEPAM 110
Metil derivati chirali di platino(II) con piridine 2-sostituite 110
Palladium(II) and Platinum(II) Derivatives with Chiral 2,2'-Bipyridines. X-ray Structure of C18H15ClN2Pd; C- and N-intramolecular Coordination in a Six-membered Metallacycle 109
Synthesis, Solution Behavior, Molecular and Supremolecular Structures of the Water-soluble Gold(I) Saccharinate Complexes M[Au(Sac)2] (M = Na, K, NH4) 109
Gold(III) derivatives with C(4)-aurated 1-phenylpyrazole RID D-3096-2011 108
Diimine Supported Group 10 Hydroxo, Oxo, Amido, and Imido Complexes 108
Gold-based drug encapsulation within a ferritin nanocage: X-ray structure and biological evaluation as potential anticancer agent of the Auoxo3-loaded protein. 108
Totale 23.736
Categoria #
all - tutte 100.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022767 0 0 3 7 6 10 52 71 93 48 87 390
2022/20232.028 215 116 27 385 222 349 10 238 313 13 86 54
2023/2024415 94 49 18 15 92 10 11 7 0 7 46 66
2024/20255.270 34 43 281 95 223 156 307 1.228 1.884 645 185 189
2025/202617.348 304 4.492 8.287 1.266 454 423 1.081 232 249 313 179 68
2026/2027920 205 542 173 0 0 0 0 0 0 0 0 0
Totale 31.583